Sipuleucel-T and Androgen Receptor-Directed Therapy for Castration-Resistant Prostate Cancer: A Meta-Analysis

New treatments, such as sipuleucel-T and androgen receptor- (AR-) directed therapies (enzalutamide (Enz) and abiraterone acetate (AA)), have emerged and been approved for the management of castration-resistant prostate cancer (CRPC). There are still debates over their efficacy and clinical benefits....

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Immunol Res
Huvudupphovsmän: Yi, Renliang, Chen, Baoxin, Duan, Peng, Zheng, Chanjiao, Shen, Huanyu, Liu, Qun, Yuan, Chen, Ou, Weilin, Zhou, Zhiheng
Materialtyp: Artigo
Språk:Inglês
Publicerad: Hindawi Publishing Corporation 2016
Ämnen:
Review Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5183769/
https://ncbi.nlm.nih.gov/pubmed/28058266
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/4543861
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk